Hinova Pharma

China
Chengdu, Sichuan, China, 610041

Company profile

Hinova Pharma company profile

Hinova Pharma is an innovative drug research and development manufacturer that provides users with compound HC-1119 androgen receptor (AR) antagonism by using drug discovery systems such as medicinal chemistry, biological screening, process research, quality research, clinical reporting, and clinical research. Drugs, HC-1102 androgen receptor inhibitors and other products, for the treatment of advanced prostate cancer and breast cancer.

Business identity

Phone number
(028) 8505 8465
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$0-$1M
Founded
2013-01-01, Year

Headquarters

Postal code
610041
Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
6
Total equity funding
$219.3M
Last funding
Series C / $147.3M / 2020-10-06
Last equity funding
Series C / $147.3M
Investors
19
Lead investors
4
Founders
2
Articles
15
Exited on
2022-04-12

Founders and investors

Founders

Xinghai LiYuanwei Chen

Lead investors

Fosun PharmaGF Xinde Investment ManagementHaiscoHermed Capital

Investors

DNV capitalFosun PharmaGF Xinde Investment ManagementHongtai Capital HoldingsInfinity Group